Lilly Just Took Major Steps Forward in Obesity Drug Market
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
This intro asks which is better for beginners in 2026: manual or robo investing, covering simplicity, risk, and learning curve for new investors.
25,920 articlesTwo bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....
As Liquidia releases its Q4 2025 results, investors crave clarity on revenue, burn rate, and milestones. This article...
Investors are parsing sector headlines as analysts cut targets for airlines and other cyclical stocks. This guide bre...
Rivian’s April milestone could reshape its growth path. This article breaks down why April could huge for Rivian, wha...
A leading home improvement stock fell 40% last quarter as growth cooled, triggering a $14 million trimming of a major...
Duolingo reported solid earnings, yet its stock moved lower. This article breaks down the investor psychology, the fo...
Embecta faced a sharp decline after its quarterly report, leaving investors wondering about the near-term outlook. Th...
When a top bank places a stock on its conviction list, it moves markets. This article explains why Goldman Sachs just...
Retirement is a chance to design a life with purpose. Explore how varying activities nurture meaning and mental healt...
A director sale can grab attention, but IPG Photonics is quietly reshaping its core business. Here’s how the brand is...
As summer approaches, investors debate whether the market is primed for a rally or headed for a slump. This guide bre...